PharmiWeb.com - Global Pharma News & Resources

Articles

Cosmetic Laser Market By Product (Ablative, Non-ablative, and Laser), Modality (Pulsed Dye Laser (PDL), YAG Laser, Carbon Dioxide Laser, Erbium, Intense Pulsed Light (IPL), Radiofrequency, Infrared, and Others), Application (Hair Removal, Skin Resurfacing, Vascular Lesions, Scar & Acne Removal, Body Contouring, and Others), and End User (Hospitals, Skin Care Clinics, and Cosmetic Surgical Centers).
Cosmetic laser is a therapy that reduces facial wrinkles and skin irregularities, such as blemishes or acne scars. This technique directs brief, concentrated pulsating beams of light at uneven surfaces of skin, which precisely removes skin layer by layer and is also known as lasabrasion technique, laser peel, or laser vaporization. It is used for treating many medical conditions such as aging ski…
Polyphthalamide Market Expected to Reach US$ 2.5 Bn by 2027. In terms of revenue, the global polyphthalamide market is anticipated to expand at a CAGR of ~ 8% from 2019 to 2027
Polyphthalamide – Opening Up Unimagined Possibilities High-temperature thermoplastics have emerged as a rapidly growing segment over the years, and continue to remain a ‘hot’ and ‘in-demand’ technology in a wide range of applications. Be it to enhance the lifespan of oil and gas assets, or a metal-replacement solution in the rapidly-expanding automotive industry, the applications of high-temperature thermoplastics, such as polyphthalamide, are becoming endless. With higher short- and long-term thermal stability, resistance to burning, chemical and radiation resistance, and superior mechanical properties, polypht…
The biggest change to the medical and pharmaceutical industry across Europe, the implementation of the Falsified Medicines Directive (FMD), came in to force in February 2019. So, three months later, what is the status of the directive across and what are the next steps for success? Oliver Pittock, managing director at pharmaceutical packaging expert, Valley Northern, explains.
The biggest change to the medical and pharmaceutical industry across Europe, the implementation of the Falsified Medicines Directive (FMD), came in to force in February 2019. So, three months later, what is the status of the directive across and what are the next steps for success? Oliver Pittock, managing director at pharmaceutical packaging expert, Valley Northern, explains. The FMD is a legal framework that was int…
Ethylene Propylene Diene Monomer (EPDM) Market will reach valuation of US$ 6.2 Bn by 2027. Global EPDM market was valued at ~ US$ 3.8 Bn in 2018, and is anticipated to expand at a CAGR of ~ 6% during the forecast period.
Ethylene Propylene Diene Monomer (EPDM) Market: Key Highlights The global ethylene propylene diene monomer (EPDM) market was valued at ~ US$ 3.8 Bn in 2018, and is anticipated to expand at a CAGR of ~ 6% during the forecast period. The global ethylene propylene diene monomer market is driven by the rise in the demand for EPDM in automotive applications such as rear-lamp gaskets, hoses, tire sidewalls, inner tire tubes, front and rear bumpers, and braking systems. Asia Pacific accounts for a major share of the global ethylene propylene die…
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain.
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E. Although, this d…
(ACN Newswire) - SGX-listed Singapore eDevelopment Ltd ("SeD", SGX:40V) is pleased to announce the results of clinical trials conducted on Laetose(TM), a low-glycemic, naturally modified sugar, developed by its U.S. biomedical subsidiary Global BioLife Inc. ("Global BioLife").
Clinical trial results show that Laetose is a new sugar product that reduces its negative impact on the body. It is a healthier sweetener that is identical to regular sugar in taste, texture and shelf life, but a naturally modified table sugar which carries 30% fewer calories and a glycemic index score of 53 as compared to a score of 100 in glucose.Laetose was developed by Mr Daryl L.Thompson, Global BioLife's Director of Scientific Initiatives, who was invited to present the new formula to health ambassadors from aro…
Leading immunoassay specialist, BBI Solutions, will demonstrate how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine tradeshow, AACC, this summer.
Leading immunoassay specialist, BBI Solutions, will demonstrate how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine tradeshow, American Association for Clinical Chemistry (AACC) exhibition, this summer. BBI’s mobile arm, Novarum™, will launch a demonstrator app that can read the results of an imitated malaria test on stand 4254 at the AACC Clinical Lab Expo, which runs from 4th-8th August in California. The app…
Here's a list of Pharma / Life Science / Clinical Research companies who are hiring in July (2019) on Pharmiweb.jobs Novartis, Roche, Syneos, Cromsource, PPD...
Here are the top Pharma and Life Science organisations hiring in July on PharmiWeb.jobs Agilent – (5 jobs) BSI Group- (4 jobs) Celgene – (39 jobs) Covance – (91 jobs) CROMSOURCE – (36 jobs) Cytel – (65 jobs) Docs Global – (51 jobs)  DS Biopharma Ltd – (1 job) Evidencia – (10 jobs) GCE Solutions – (8 jobs) Grunenthal GmbH- (15 jobs) IQVIA – (35 jobs) IQVIA Biotech – (29 jobs) LINICAL Spain – (2 jobs) Lonza – (6 jobs) Molnlycke – (1 job) Novartis – (90 jobs) Oxford BioMedica (UK) Limited – (17 jobs) Parexel – (61 jobs) PPD – (101 jobs) PRA Health Sciences – (39 jobs) Premier Research – (17 jobs) Richmond Pharmacology – (1 job)  Roch…
Cell and gene therapies and tissue-engineered products have the potential to offer a durable, life-changing effect, possibly with single administration
Cell and gene therapies and tissue-engineered products have the potential to offer a durable, life-changing effect, possibly with single administration New report from Alliance for Regenerative Medicine and UK BioIndustry Association highlights progress in financing and clinical trials 24% of Europe’s ATMP developers headquartered in the UK WASHINGTON, D.C. and LONDON, UK – 18 July 2019 The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader advanced therapies sector, and the BioIndustry Association (BIA), the trade association for innovative enterprises involve…
Translational science and research organisation, Fera Science Ltd, has hosted its Advances in Environmental Risk Assessments symposium, inviting members of the PPP industry to come together and discuss how to develop new solutions that will support an increase in agricultural outputs.
Plant protection products (PPPs) used in agriculture have doubled in numbers since the 1980s. Without them, the food safety of billions of people would be threatened. But the PPP chemical industry continues to face ongoing debate to ensure that these products raise the quality and yield crops with minimal impact on the surrounding environment. To help facilitate this debate, Translational science and research organisation, Fera Science Ltd, has hosted its Advances in Environmental Risk Assessments symposium…
A spotlight on Nicola Murgatroyd, founder of Phlexglobal, now working in healthcare tech… What are your thoughts on the clinical research industry today?
What are your thoughts on the clinical research industry today?Having been outside it for nearly ten years now, its interesting to see the industry from another perspective. I’d say that not many people, in fact very few people in the UK, know very much about Pharmaceutical companies or clinical trials. Though its an industry that relieves pain and suffering, and one that I was always proud to work in, unfortunately the general publics view is still often one of it being rich and uncaring. Do you think more could be done to change the publics view?If people feel more like a captive market than a patient, the perception that Pharma co…
Surge in the prevalence of chronic diseases, and thriving demand and development of monoclonal antibodies (mAbs) are the key factors driving the market growth.
Checkpoint inhibitors and vaccines are the two major types of immunotherapy drugs analyzed in the report. Of these, checkpoint inhibitors held a larger share in the immunotherapy drugs market, accounting for 66.3% in 2017. Checkpoint inhibitors are the first preference for the treatment of chronic diseases, as they provide better and effective treatment results. These drugs act directly on site of action, without delaying the effect of medicine, and are thus being highly adopted for the treatment of several diseases. Some of the major checkpoint inhibitors brand available in the market are Humira, Rituxan/MabThera, Herceptin, Remicad…
As time goes on and technology improves beyond our wildest dreams, people no longer have the time or patience to read paragraphs and paragraphs of information. People want information and they want it fast—paving the way for digital content to make appearances in almost every website, article, and social platform. Let’s talk about how Visual content can help get your name out there and grow your business.
How Visual Content Can Help Grow Your Business   As time goes on and technology improves beyond our wildest dreams, people no longer have the time or patience to read paragraphs and paragraphs of information. People want information and they want it fast—paving the way for digital content to make appearances in almost every website, article, and social platform. Let’s talk about how V…
Merck KGaA, Thermo Fisher Scientific Inc. and Applikon Biotechnology BV - Notable Market Participants in Bioreactors Industry
The bioreactors market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the bioreactors market are present globally and have wide distribution and sales network through partnerships or authorized dealers. The most notable market participants are Thermo Fisher Scientific Inc., Applikon Biotechnology BV, Merck KGaA, Sartorius AG, Eppendorf, General Electric, Bioengineering AG, Solaris Biotechnology Srl, Danaher (Pall Corporation), and Praj Industries occupying a considerable share of the market owing to their offerings to the market. The global bioreactors…
The pharma industry is in the midst of a significant transformation, driven by technological advances, geopolitical uncertainty, the urbanisation of emerging economies and changes in consumer behaviour and expectations. In this modern sales era, it’s no longer sufficient for sales teams to simply learn about customer needs or issues, and then provide them with solutions through products or services. While those practices do remain at the core of sales, success now depends on organisations providing additional value during the sales process.
Richard Hilton, Managing Director EMEA at Miller Heiman Group, talks about how pharmaceutical businesses can maximise their workforces through targeted apprenticeship levy funding The pharma industry is in the midst of a significant transformation, driv…
June 27, 2019 - Recent advances in artificial intelligence and precision medicine led to the emergence of new businesses that trade and process human health data. Most pharmaceutical companies are acquiring large volumes of clinical and other data for research and marketing purposes. However, there are few examples of companies turning this data into new therapeutic products and it is difficult to estimate the potential benefits stemming from a specific data type or a combination. Unlike in finance, where there are established methods for pricing anything from money to complex derivative securities, there are no established models for estimating the value of human life data.
June 27, 2019 - Recent advances in artificial intelligence and precision medicine led to the emergence of new bu…
Despite being one of the most productive industries in the UK, pharmaceutical manufacturers are facing a number of key challenges, including responding to changing consumer demands. These consequences also impact the original equipment manufacturers (OEMs) that supply their machines. The sector requires that its OEMs manufacture systems with ever-shorter run times, greater flexibility, and increased efficiency in order for their customers to stay competitive.
Serving up finance: OEMs can help their customers in the pharmaceuticals sector embrace digitalisation with integrated finance Gary Thompson, Sales Director, Siemens Financial Services (UK) Despite being one of the most productive industries in the UK,[1] pharmaceutical manufacturers are facing a number of key challenges, including…
As reported recently, in the last six years, nearly 600 GP surgeries have closed, affecting almost two million patients. The closures have been blamed on underfunding, under-resourcing and an ongoing recruitment crisis. Here, Oliver Pittock, managing director of healthcare consumables supplier Valley Northern, comments.
As reported recently, in the last six years, nearly 600 GP surgeries have closed, affecting almost two million patients. The closures have been blamed on underfunding, under-resourcing and an ongoing recruitment crisis. Here, Oliver Pittock, managing director of healthcare consumables supplier Valley Northern, comments. The coming years will be crucial for the NHS. It’s been suggested that in the next five years, the NHS could be short of 7,000 GP’s if the budget for traini…
According to a recent report, care home residents account for around 250,000 emergency hospital admissions each year. However, it’s estimated that 40 per cent of these admissions could be avoided with a better understanding of a resident’s health needs and the medication they consume. But what can be done to reduce this figure? Here, Adrian Pittock, marketing director of healthcare consumables supplier, Valley Northern, explains more.
According to a recent report, care home residents account for around 250,000 emergency hospital admissions each year. However, it’s estimated that 40 per cent of these admissions could be avoided with a better understanding of a resident’s health needs and the medication they consume. But what can be done to reduce this figure? Here, Adrian Pittock, marketing…
Bispecific antibodies (BsAbs) are a class of bifunctional antibody hybrid molecules. The Fab segments in bivalent antibodies have different specificities and can bind to different ligands. Anti-tumor and anti-immunologically active cells CDl6 or CD3 bispecific antibodies not only have the effect of activating NK cells or T cells, but also can specifically act on tumor cells through anti-tumor Fab segments to increase local NK cell or T cell concentration and enhance the ability of effector molecules to kill tumors.
Bispecific antibodies (BsAbs) are a class of bifunctional antibody hybrid molecules. The Fab segments in bivalent antibodies have different specificities and can bind to different ligands. Anti-tumor and anti-immunologically active cells CDl6 or CD3 bispecific antibodies not only…